| European Case Law Identifier: | ECLI:EP:BA:1994:T088691.19940616 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 16 June 1994 | ||||||||
| Case number: | T 0886/91 | ||||||||
| Application number: | 79303017.2 | ||||||||
| IPC class: | C12N 15/00 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | B | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Recombinant DNA, hosts transformed with it and polypeptides produced by the hosts; processes for their preparation; detection processes using the polypeptides; compositions and means containing the polypeptides; DNA sequences. | ||||||||
| Applicant name: | BIOGEN, INC. | ||||||||
| Opponent name: | (01) Abbott Laboratories (02) Takeda Chemical Industries, Ltd (03) Warcoin, Jacques Cabinet REGIMBEAU (04) SmithKline Beecham Corporation (05) Institut Pasteur Etablissement public Medeva PLC (Intervener) |
||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Admissibility of intervention of assumed infringer during appeal (yes) Entitlement to priority Sufficiency of disclosure (yes) Industrial applicability (yes) Citability of document published between the second and third priority dates against subject-matter entitled to the third priority or filing date (yes) Novelty (yes) Inventive step-main request (no) Inventive step-first auxiliary request (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t910886eu1.html
Date retrieved: 17 May 2021